These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6378356)

  • 1. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
    Sogani PC; Vagaiwala MR; Whitmore WF
    Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
    Sogani PC; Whitmore WF
    J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment.
    Sogani PC; Ray B; Whitmore WF
    Urology; 1975 Aug; 6(2):164-6. PubMed ID: 1145932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flutamide therapy for advanced prostatic cancer: a phase II study.
    MacFarlane JR; Tolley DA
    Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide as primary treatment for metastatic prostatic cancer.
    Lundgren R
    Br J Urol; 1987 Feb; 59(2):156-8. PubMed ID: 3828712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
    Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
    Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
    Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
    Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
    N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide--an antiandrogen inhibiting prostatic cancer and prostatic secretion with retention of potency.
    Stegmayr B; Johansson JE; Schnürer LB
    Med Oncol Tumor Pharmacother; 1988; 5(1):61-5. PubMed ID: 3367673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutamide in the treatment of metastatic carcinoma of the prostate.
    Narayana AS; Loening SA; Culp DA
    Br J Urol; 1981 Apr; 53(2):152-3. PubMed ID: 7237048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antiprostatic agent for treatment of prostatic carcinoma.
    Irwin RJ; Prout GR
    Surg Forum; 1973; 24():536-7. PubMed ID: 4806089
    [No Abstract]   [Full Text] [Related]  

  • 14. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
    Lund F; Rasmussen F
    Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation with long-term follow-up of flutamide and estramustine as initial treatment of metastatic carcinoma of the prostate.
    Johansson JE; Andersson SO; Beckman KW; Zador G
    Am J Clin Oncol; 1988; 11 Suppl 2():S183-6. PubMed ID: 3242386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.
    Labrie F; Dupont A; Cusan L; Manhès G; Bergeron N; Lacourcière Y; Pineault S; Bélanger A; Monfette G; Emond J
    Prog Clin Biol Res; 1989; 303():161-7. PubMed ID: 2674982
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
    de Kernion JN; Murphy GP; Priore R
    Urology; 1988 Apr; 31(4):312-7. PubMed ID: 3281365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
    Sogani PC; Whitmore WF
    Cancer Treat Res; 1988; 39():131-45. PubMed ID: 2908604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
    Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
    Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
    Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
    Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.